Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cAMP metabolic process modulation refers to any biological process that alters the frequency, rate, or extent of chemical reactions and pathways involving cyclic adenosine monophosphate (cAMP). cAMP is a key second messenger in cellular signaling, synthesized from ATP by adenylyl cyclase and degraded by phosphodiesterases. It regulates diverse physiological responses across many cell types through effectors like PKA, Epac, and CNG channels. Modulation of this pathway is implicated in endocrine, cardiovascular, and immune-related diseases.
Modulation of cAMP levels via influencing synthesis (adenylyl cyclase) or degradation (phosphodiesterases) or by directly targeting downstream effectors like PKA or Epac.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on cAMP Metabolic Process Modulation.